EP122 TREATMENT OF CHRONIC WOUNDS IN ISCHEMIC LOWER EXTREMITIES WITH NOVEL FISH SKIN--DERIVED MATRIX: A PROSPECTIVE, RANDOMIZED, CONTROLLED STUDY...European Wound Management Association (EWMA) Conference, May 3-5, 2023, Milan, Italy.
Aim: To evaluate the efficacy of treatment in the chronic wounds of patients with ischemia of the lower extremities, we compared an omega-3 wound matrix product (Kerecis, Isafjordur, Iceland) with a standard dressing. Method: We performed a single-center, prospective, randomized, controlled clinical...
| Publicado en: | Journal of Wound Management Vol. 24; no. 2; pp. 97 - 99 |
|---|---|
| Autores principales: | , |
| Formato: | abstract pictorial proceedings research tables/charts randomized controlled trial Journal Article |
| Publicado: |
Cambridge Publishing
Jul2023
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=164968836&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 164968836 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 27885771 MZEQ jtl: Journal of Wound Management issn: 27885771 maglogo: N pubinfo: dt: Jul2023 vid: 24 iid: 2 pid: 66266 pub: Cambridge Publishing artinfo: ui: 164968836 164968836 164968836 164968836 ppf: 97 ppct: 2 formats: fmt: @attributes: type: P tig: atl: EP122 TREATMENT OF CHRONIC WOUNDS IN ISCHEMIC LOWER EXTREMITIES WITH NOVEL FISH SKIN--DERIVED MATRIX: A PROSPECTIVE, RANDOMIZED, CONTROLLED STUDY...European Wound Management Association (EWMA) Conference, May 3-5, 2023, Milan, Italy. aug: au: Hyung-Sup Shim Hyeju Han affil: The Catholic University of Korea, St. Vincent's Hospital, Suwon, Korea, Rep. of South sug: subj: Wounds, Chronic Therapy Ischemia Lower Extremity Pathology Fatty Acids, omega-3 Therapeutic Use Fish Therapeutic Use Skin Transplantation Allografts Bandages and Dressings Treatment Outcomes Evaluation Congresses and Conferences Italy Italy ab: Aim: To evaluate the efficacy of treatment in the chronic wounds of patients with ischemia of the lower extremities, we compared an omega-3 wound matrix product (Kerecis, Isafjordur, Iceland) with a standard dressing. Method: We performed a single-center, prospective, randomized, controlled clinical trial of patients with a wound that failed to heal following 3 weeks of conservative care. The ischemic condition was confirmed as decreased transcutaneous oxygen pressure (TcPO2) < 40 mmHg. After randomizing patients into a case and a control group, the weekly decrease in wound area over 12 weeks and the number of patients that achieved complete wound closure were compared between the two groups. Patients with TcPO2≤32 mmHg were further extracted to analysis in a severe ischemic context. Results / Discussion: 28 patients were assigned to the case group and 22 patients to the control group. During 12 weeks, the wound area decreased more rapidly in the case group than the control group. Complete wound healing occurred in 82% in the case group and 45% in the control group. Even in patients with a severe ischemic wound with TcPO2 value < 32 mmHg, wound area decreased more rapidly in the case group than the control group. The proportions of epithelized area in the groups were 80.24% and 57.44%, respectively. Conclusion: Considering the more rapid decrease in wound area and complete healing ratio in the case group, application of a fish skin--derived matrix for treating lower-extremity chronic wounds, especially in chronic wounds in ischemic lower extremities, is a good treatment option. pubtype: Academic Journal doctype: abstract pictorial proceedings research tables/charts randomized controlled trial Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|